# OnCo record car-t-apheresis (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/car-t-apheresis/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "car-t-apheresis" ;
  schema:name "Leukapheresis to collect T cells for CAR T-cell manufacture"@en ;
  schema:alternateName "leukapheresis for CAR T"@en, "T-cell collection"@en, "apheresis for CAR-T"@en, "starting material collection"@en, "unmobilised leukapheresis"@en ;
  schema:description "Every CAR T-cell treatment made from your own cells starts with leukapheresis: over a few hours, blood is taken from a vein, a machine keeps the white cells it needs, and the rest is returned. The date is booked with the manufacturer. Where possible it is done before more chemotherapy, which can weaken the T cells, and some recent treatments need a gap before collection."@en ;
  schema:url <https://onco.cc/protocols/car-t-apheresis/> ;
  schema:dateModified "2026-11-11"^^xsd:date ;
  onco:tag "protocol", "cell-therapy", "car-t" ;
  onco:related <https://onco.cc/protocols/car-t-bridging/>, <https://onco.cc/protocols/car-t-lymphodepletion/> ;
  onco:technologies <https://onco.cc/technologies/car-t/>, <https://onco.cc/technologies/apheresis-starting-material/>, <https://onco.cc/technologies/car-t-manufacturing-process/> ;
  onco:drugs <https://onco.cc/drugs/axicabtagene-ciloleucel/>, <https://onco.cc/drugs/tisagenlecleucel/>, <https://onco.cc/drugs/lisocabtagene-maraleucel/>, <https://onco.cc/drugs/brexucabtagene-autoleucel/>, <https://onco.cc/drugs/idecabtagene-vicleucel/>, <https://onco.cc/drugs/ciltacabtagene-autoleucel/>, <https://onco.cc/drugs/obecabtagene-autoleucel/> ;
  onco:terms <https://onco.cc/terms/apheresis/>, <https://onco.cc/terms/lymphoma-tx-car-t-pathway/> .